A
Anthony S. Russell
Researcher at University of Alberta
Publications - 316
Citations - 17857
Anthony S. Russell is an academic researcher from University of Alberta. The author has contributed to research in topics: Rheumatoid arthritis & Ankylosing spondylitis. The author has an hindex of 60, co-authored 308 publications receiving 16327 citations. Previous affiliations of Anthony S. Russell include University of Kansas & Cross Cancer Institute.
Papers
More filters
Journal ArticleDOI
The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity.
Frederick Wolfe,Daniel J. Clauw,Mary Ann Fitzcharles,Don L. Goldenberg,Robert S. Katz,Philip J. Mease,Anthony S. Russell,I. Jon Russell,John B. Winfield,Muhammad B. Yunus +9 more
TL;DR: To develop simple, practical criteria for clinical diagnosis of fibromyalgia that are suitable for use in primary and specialty care and that do not require a tender point examination, and to provide a severity scale for characteristic fibromyalgic symptoms.
Journal ArticleDOI
Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia
Frederick Wolfe,Daniel J. Clauw,Mary Ann Fitzcharles,Don L. Goldenberg,Winfried Häuser,Robert S. Katz,Philip J. Mease,Anthony S. Russell,I. Jon Russell,John B. Winfield +9 more
TL;DR: A fibromyalgia survey questionnaire is developed using a modification of the 2010 American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia (ACR 2010) to allow their use in epidemiologic and clinical studies without the requirement for an examiner.
Journal ArticleDOI
2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria
Frederick Wolfe,Daniel J. Clauw,Mary Ann Fitzcharles,Don L. Goldenberg,Don L. Goldenberg,Winfried Häuser,Robert L. Katz,Philip J. Mease,Anthony S. Russell,Irwin Jon Russell,Brian Walitt +10 more
TL;DR: A (2016) revision to the 2010/2011 fibromyalgia criteria combines physician and questionnaire criteria, minimizes misclassification of regional pain disorders, and eliminates the previously confusing recommendation regarding diagnostic exclusions.
Journal ArticleDOI
Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial.
Joel M. Kremer,Harry K. Genant,Larry W. Moreland,Anthony S. Russell,Paul Emery,Carlos Abud-Mendoza,Jacek Szechiński,Tracy Li,Zhiyu Ge,Jean-Claude Becker,Rene Westhovens +10 more
TL;DR: Patients who received abatacept more often had improved physical function, more frequently met standard response criteria, and less often had radiographic progression of joint damage, as well as serious infections and infusion reactions more often.
Journal ArticleDOI
Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed
L. B. A. Van De Putte,C Atkins,Michel Malaise,J Sany,Anthony S. Russell,P.L.C.M. van Riel,L. Settas,J. W. J. Bijlsma,S Todesco,Maxime Dougados,Peter Nash,Paul Emery,N Walter,M Kaul,S Fischkoff,H Kupper +15 more
TL;DR: Among patients with RA for whom previous DMARD treatment had failed, adalimumab monotherapy achieved significant, rapid, and sustained improvements in disease activity and improved physical function and was safe and well tolerated.